Taunton-Rigby takes on a turnaround
Cambridge Biotech Corp. took its first step toward turning around the company, which went into Chapter 11 in July 1994, appointing Alison Taunton-Rigby president and CEO.
Taunton-Rigby told BioCentury she was attracted to Cambridge Biotech by its strong technology base, the fact that it already has products on the